Roivant Sciences Total Liabilities increased by 65.8% to $416.28M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.7%, from $249.74M to $416.28M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -4.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $474.87M | $652.01M | $529.62M | $523.70M | $822.52M | $701.39M | $775.82M | $782.02M | $802.51M | $739.91M | $728.10M | $773.95M | $601.16M | $625.99M | $256.38M | $249.74M | $216.70M | $257.14M | $251.14M | $416.28M |
| QoQ Change | — | +37.3% | -18.8% | -1.1% | +57.1% | -14.7% | +10.6% | +0.8% | +2.6% | -7.8% | -1.6% | +6.3% | -22.3% | +4.1% | -59.0% | -2.6% | -13.2% | +18.7% | -2.3% | +65.8% |
| YoY Change | — | — | — | — | +73.2% | +7.6% | +46.5% | +49.3% | -2.4% | +5.5% | -6.2% | -1.0% | -25.1% | -15.4% | -64.8% | -67.7% | -64.0% | -58.9% | -2.0% | +66.7% |